The following article was featured in:
Source:
Your Health Matters
12/11/2025.
Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced ....
Continue on to full article...
